ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Posts Basic Consolidated EPS Of $-1.6341

0

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)managed to report annual basic consolidated EPS of $-1.6341, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-1.6341 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.6295.

EPS contribution from parent

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) received of $-1.6341 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) contributed EPS of $-1.6341 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-1.6341.

What About Basic net EPS

The basic net EPS that ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported for the year ended 2015-12-31 stood at $-1.63. For the quarter ended 2015-12-31, the company posted basic net EPS of $-1.63.

What About Consolidated Diluted EPS?

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-1.6341. For the quarter ended 2015-12-31 the metric was$-1.6341.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-1.6341 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-1.6341.

Net diluted EPS

Net diluted EPS posted by ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for the year ended 2015-12-31 was $-1.63. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-1.63.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) said that it parent company boosted its diluted EPS by$-1.6341 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-1.6341.

The company reported net basic EPS of $-1.63 for the year ended 2015-12-31 and net basic EPS of $-1.63 for the quarter ended 2015-12-31.

The number of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 100.63. That compares with 100.63 basic shares outstanding for the quarter ended 2015-12-31.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had 100.63 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 100.63.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 60 times, 1 visits today)